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Abstract
Background: Approximately 287,000 women die of causes related to pregnancy and childbirth every year. While
effective interventions exist to prevent maternal death, high quality impact evaluations for these interventions are
often lacking.
Methods: We conducted a Delphi process consisting of three rounds in which we asked maternal health experts
to provide effectiveness estimates for 31 intervention-cause of death pairs relating to maternal mortality.
Anonymous feedback in the form of medians and histograms for each question was given to experts following the
first and second rounds. A diverse panel of 37 experts completed all three rounds, for a final response rate 80.4%.
Results: This Delphi process produced a total of 31 effectiveness estimates for key maternal interventions on
cause-specific maternal mortality. Overall, many interventions had high estimated effectiveness, with the majority of
interventions having effectiveness estimates above 70%. Where possible, the estimates of effectiveness of
interventions were compared to previous efforts and in general there was strong agreement between the
estimates in this exercise as compared to those of earlier efforts.
Conclusions: There are many maternal health interventions with high estimated effectiveness that, with expansion
of effective delivery channels, have the potential to have a large impact on reducing maternal mortality worldwide.
Background
Every year, approximately 287,000 women die of causes
related to pregnancy and childbirth worldwide, with
nearly all of those deaths occurring in low- and middle-
income countries [1]. While effective interventions and
packages exist to prevent maternal death, high-quality
impact evaluations generated from randomized trials or
large observational studies are often lacking due to the
large sample sizes required to detect statistical differences
in mortality. In addition, some maternal interventions
that have been routine practice for decades, such as cae-
sarean sections, will never be studied through rando-
mized trials due to ethical considerations. Furthermore,
the effects of specific interventions normally found within
packages are difficult to assess in experimental studies.
For such interventions, it is necessary to obtain effective-
ness estimates through other methods.
We set out to conduct this Delphi analysis to generate
the best estimates for specific interventions on causes of
maternal death, and to use these estimates to update the
maternal model in the Lives Saved Tool (LiST) in light
of the World Health Organization (WHO)’s new cause
of death structure for maternal mortality [2]. LiST is a
computer-based model that estimates the impact of scal-
ing up interventions on maternal and child mortality,
along with other health outcomes (e.g., stunting rates,
stillbirths, diarrhea incidence) to help guide program
planning [3]. The development of the LiST model has
been directed by the Child Health Epidemiology Refer-
ence Group (CHERG) of WHO and the United Nations
Children’s Fund (UNICEF). This group has developed a
set of standards by which interventions should be
included in the model and how estimates of intervention
effectiveness should be developed. For interventions
where there is clear clinical/preventive benefit of an
intervention but no data available, a Delphi approach
could be used to generate estimates of the effectiveness
of these interventions [4,5].
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The Delphi method, developed by the RAND Corpora-
tion in 1948, is a method by which consensus is achieved
through an iterative process by a panel of experts. The
method was originally developed in defense research for
scientific and technological forecasting purposes. Essential
components of the Delphi method include anonymous
response, iteration and controlled feedback, and a statisti-
cal definition of consensus [6]. It has been used historically
in a variety of disciplines, and has been applied to a variety
of areas within the field of health and medicine [7-10].
The Delphi method is thus a widely-accepted and useful
tool for generating estimates in the absence of sufficient
evidence from experimental studies.
Previously, WHO sponsored a Delphi exercise to esti-
mate the impact of interventions on maternal and neona-
tal mortality [unpublished manuscript, WHO]. The
purpose of WHO’s previous Delphi analysis was to identify
areas of consensus and disagreement regarding the efficacy
of newborn and maternal health interventions, with the
ultimate goal of evaluating the cost-effectiveness of these
interventions [unpublished manuscript, WHO]. The esti-
mates of effectiveness along with others generated within
the CHERG framework [11] were used for the estimates of
effectiveness in LiST. Recently, WHO redefined the cate-
gories within cause-specific maternal mortality, and there-
fore the estimates of effectiveness needed to be updated to
reflect this new set of mortality causes.
In this paper, we describe the process by which these
consensus estimates were generated and discuss the key
findings of this Delphi analysis. In addition, we outline
how these results will be incorporated into the maternal
model in LiST. It is important to note that this study does
not constitute a literature review or meta-analysis, but
rather presents a series of effectiveness estimates gener-
ated through an iterative process involving a group of
experts in maternal health.
Methods
Participants
We identified 90 international experts in maternal health
and contacted them by email for participation in this
study. The original set of experts we contacted was
selected by identifying researchers who had worked with
the CHERG and asking those people to suggest other par-
ticipants. The pool also included some experts in maternal
health who had participated in a prior Delphi panel with
WHO. We tried to ensure diversity in professional experi-
ence and in geographic background, and to achieve a mix
of experts in public health research and clinical work, and
those with familiarity or experience in global health.
Of the 90 experts we contacted, 46 completed the
initial questionnaire. The response rate for round one
was 100% by definition. Four experts declined to
participate, and 40 did not respond. 40 of the 46 experts
who completed the round one questionnaire completed
round two, for a response rate of 87%. The final response
rate was 82.6%, with 38 out of the original 46 experts
completing the third round. One of these 38 experts
completed the third round, but did not complete the sec-
ond round.
Of the experts who completed the round one ques-
tionnaire, a slight majority were female. Expert panel
members represented 22 different nationalities and
worked in every region of the globe.
The expert panel was comprised primarily of obstetri-
cians and researchers, with nurse/midwives also being
represented. In addition to being physicians and nurses,
11 clinical experts identified themselves as researchers,
and three identified education as a secondary profession.
A majority of the experts had medical degrees, and
many had more than one degree (see Table 1).
Materials
We developed a questionnaire in which experts were
asked to provide estimates for the effectiveness of the
specified intervention on a specific cause of maternal
death. We developed the questions through consultation
and pilot testing with several maternal health experts
over a six-month period. We began the process with 23
individual interventions and three packages coming pri-
marily from LiST’s current maternal and neonatal health
models. We identified seven categories of causes of
maternal death based on the most recent cause of
maternal death structure developed by WHO [2]. Initi-
ally, all possible intervention-cause of death pairs were
included; throughout the piloting phase, we excluded
questions that were likely to produce negligible effects
on the prevention of maternal deaths. The final ques-
tionnaire had a total of 31 questions.
The questions were framed in such a way that experts
were asked to provide effectiveness estimates for the
intervention on maternal deaths due to a specific cause.
For example, we asked for the effectiveness of calcium
supplementation on maternal deaths due to pre-eclamp-
sia/eclampsia. We specified in the instructions that
interventions were assumed to be timely and of high
quality. The experts had the option to complete the
questionnaire through an online form or to complete a
Word document version of the questionnaire and send
through email.
Procedures
Rounds and group feedback
We decided a priori to run three rounds of this ques-
tionnaire. Three rounds are generally accepted as appro-
priate to balance attrition rate and fatigue against
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conducting a sufficient number of rounds to reach con-
sensus [12]. The purpose of the initial round was for
experts to provide their initial estimates for each of 31
intervention-cause of death pairs. The second and third
rounds were to allow the experts to revise their
responses based on group feedback. In the second
round, experts were provided with their individual
responses to round one, the median of the group
responses, and a histogram of group responses for each
question. In the third round, experts were provided with
individual responses, medians, and histograms for round
two; if desired, experts could also refer to the responses
from round one. We hoped that by providing the full
range of responses in a histogram instead of just provid-
ing feedback in the form of a mean or median value, we
would reduce the pressure on individual respondents to
conform to median values. All 31 questions were
included in the each round regardless of whether con-
sensus had been achieved in previous rounds.
Definition of consensus
Consensus was defined to be an interquartile range
(IQR) of 20 percentage points or fewer. The median
response was used as the final effectiveness estimate.
Results
We first conducted an analysis to characterize changes in
effectiveness estimates and the degree of consensus across
rounds. We then present the resulting effectiveness esti-
mates for each intervention-cause of death pair across all
rounds.
Changes in effectiveness estimates and degree of
consensus across rounds
The median change in response for all responses for all
questions was 0 [IQR: -5,5] percentage points from
round one to round two, ranging from -85 to 78. The
median change was 0 [IQR: 0,0] percentage points from
round two to round three, ranging from -53 to 95. The




Region Nationality, n (%) Experts working in each region, n (%)*
Europe 10 (21.7) 21 (7.1)
Americas
U.S./Canada 9 (19.6) 3 (4.3)
Latin America 4 (8.7) 10 (8.6)
Southeast Asia 8 (17.4) 7 (25.7)
Western Pacific 7 (15.2) 5 (14.3)
Africa 5 (10.9) 18 (30)
Eastern Mediterranean 3 (6.5) 6 (10)
Total 46 (100) 70 (100)
Profession n (%)
Obstetrician/Gynecologist 30 (65.2)
Researcher/Academic/ Epidemiologist 8 (17.3)
Nurse/midwife 5 (10.9)
Other physician 2 (4.3)
Public health practitioner 1 (2.2)
Total 46 (100)
Professional experience Median
Median years working in profession 30
Academic Qualifications n (%)
Doctorate 5 (10.9)
Master’s Degree 2 (4.4)
Medical Degree plus further qualification 19 (41.3)
Medical degree 16 (34.8)
Nursing degree plus further qualification 3 (6.52)
Nursing degree 1 (2.17)
Total 46 (100)
*The total for this column is greater than number of experts, as some experts work in multiple regions.
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IQRs for all intervention-cause of death pairs diminished
from round to round. The IQRs in round one ranged
from five to 63.75, with a median IQR of 36.25 [IQR:
25, 43.75]. The IQRs in round two ranged from five to
41.25, with a median of 20 [IQR: 14.25, 26.25]. In round
three, the median IQR of all the pairs was 15 [IQR: 10,
20], ranging from 3.75 to 30.
Effectiveness values by round and final effectiveness
values
The effectiveness estimates and IQRs for the final round
are presented in Table 2. Many interventions had high
estimated effectiveness, with 18 out of 31 intervention–
cause of death pairs having 70% estimated effectiveness
or higher. Interventions to prevent maternal deaths due
to hypertensive disorders of pregnancy (HDPs) had
effectiveness estimates of 50% or less, except for inter-
ventions that included MgSO4 (anti-convulsants: 60%
effectiveness, Basic Emergency Obstetric Care [BEmOC]:
60% effectiveness, Comprehensive Emergency Obstetric
Care [CEmOC]: 85% effectiveness). Safe abortion services
and post-abortion care were both estimated to be highly
effective against deaths due to abortion (95% and 80%
effectiveness, respectively), and ectopic pregnancy case
management had a comparably high estimated effective-
ness against ectopic pregnancy deaths (90% effective-
ness). Parenteral antibiotics and packages that include
them (BEmOC, CEmOC) were more effective than clean
delivery practices or blood transfusion against deaths due
to pregnancy-related sepsis according to our estimates
(see Table 2).
CEmOC was estimated to be highly effective against
deaths due to antepartum hemorrhage (APH) (90%
effectiveness) as compared to BEmOC (40% effective-
ness). Caesarean section and CEmOC had the highest
estimated effectiveness against obstructed labor deaths
(effectiveness 90% and 95%, respectively), and packages
of interventions such as active management of the third
stage of labor (AMTSL) (70% effectiveness), BEmOC
(75%), and CEmOC (90%) were highly effective against
deaths due to postpartum hemorrhage (PPH). Finally,
intermittent preventive treatment in pregnancy (IPTp)/
insecticide-treated nets (ITNs) and malaria case man-
agement had moderately high effectiveness estimates
against malaria-specific maternal deaths (72.5% and
80%, respectively), and adult antiretrovirals (ARVs) had
an effectiveness estimate of 70% against maternal deaths
due to HIV. Interestingly, CEmOC not only had high
estimated effectiveness against five causes of maternal
death (pre-eclampsia/eclampsia, pregnancy-related sep-
sis, APH, obstructed labor, and PPH), but the uncer-
tainty for the effectiveness of CEmOC against these
causes of death was also low, with IQRs of 10 or nar-
rower for all five estimates.
Discussion
Overall, most interventions showed high estimated effec-
tiveness, suggesting that there are many highly-effective
Table 2 Effectiveness estimates and interquartile ranges for maternal interventions on cause-specific maternal
mortality








Calcium supplementation Pre-eclampsia / eclampsia *20 [15,30] BEmOC APH 40 [25,50]
Anti-convulsants (MgSO4) Pre-eclampsia / eclampsia *60 [50,70] CEmOC APH *90 [90,95]
BEmOC Pre-eclampsia / eclampsia *60 [50,70] Assisted vaginal delivery Prolonged and
obstructed labor
*38.8 [30,45]
CEmOC Pre-eclampsia / eclampsia *85 [80,90] Caesarean section Obstructed labor *90 [85,90]
Hypertensive therapy HDPs 50 [30,60] Blood transfusion Obstructed labor *25 [20,30]
Induction of labor HDPs 42.5 [25,50] CEmOC Obstructed labor *95 [90,95]
Caesarean section HDPs *45 [30,50] Uterotonics (prevention) PPH *77.5 [60,80]
Safe abortion services Induced abortion *95 [90,95] Uterotonics (treatment) PPH *80 [70,90]
Post-abortion care Induced abortion *80 [70,90] AMTSL PPH *70 [60,80]
Blood transfusion Abortions and ectopic
pregnancy





Ectopic pregnancy *90 [85,95] BEmOC PPH *75 [60,80]
Clean delivery practices Sepsis-pregnancy 60 [50,75] CEmOC PPH *90 [90,95]
Parenteral antibiotics Sepsis-pregnancy *80 [70,85] ARVs HIV/AIDS *70 [60,80]
Blood transfusion Sepsis-pregnancy *25 [20,30] IPTp/ITNs Malaria (P. falciparum) *72.5 [70,80]
BEmOC Sepsis-pregnancy *70 [60,80] Malaria case
management
Malaria (P. falciparum) *80 [75,90]
CEmOC Sepsis-pregnancy *90 [80,90]
*IQR ≤ 20 percentage points
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interventions to prevent maternal death. Even interven-
tions such as MgSO4, which can be delivered at small
community health centers as opposed to hospitals, are
estimated to be very effective against maternal death
due to a variety of causes. These results suggest that the
next step in combating maternal mortality may be to
develop better ways to deliver these interventions
to communities that are the most in need, as opposed to
developing and testing new interventions. With regard to
group agreement, the IQRs for nearly all intervention-
cause of death pairs decreased across rounds, indicating
consistent movement toward consensus. By the final
round, a total of four intervention-cause of death pairs
had an IQR of effectiveness estimates greater than 20
percentage points, although none of these had an IQR
greater than 30 percentage points. Two of these pairs
were related to HDPs and are discussed later. One of
these pairs asked for the effectiveness of clean delivery
practices on maternal deaths due to pregnancy-related
sepsis. As clean delivery practices are an intervention
more often associated with newborn health, experts may
have been less familiar or confident in their ability to
assess the impact of this intervention on maternal mor-
tality. It is also interesting to note that while the IQR of
the estimates of effectiveness did get smaller over the
rounds, the mean and median point estimates did not
change by a large degree for most intervention-outcome
pairs.
There are several strengths to our study that likely
enhance the validity of our results. First, a diverse panel of
experts participated in this Delphi process, representing
multiple professions, 22 different nationalities, and work-
ing in many countries in all regions of the world. This
diversity promotes a more predictive and valid consensus
in studies related to health [13]. Furthermore, we rigor-
ously pilot-tested our questionnaire with multiple mater-
nal health experts prior to the actual Delphi process in
order to ensure that questions and definitions were as
clear and complete as possible. Another important advan-
tage to our approach was the format of the feedback pro-
vided to our experts. While many Delphi processes may
provide only median values or IQRs as post-round feed-
back, our experts were provided with median values in
addition to a histogram with all responses from the pre-
vious round. This form of feedback allowed experts to
consider the full range of responses and to better assess
group consensus as they provided their revised answers.
The estimates generated from this Delphi analysis, in
conjunction with estimates generated from other sources,
will be used in the maternal mortality model in LiST.
Each intervention-cause of death pair and the corre-
sponding effectiveness estimate from this Delphi process
will represent a link in the model, and all pairs described
in this paper will be included in the final model. We will
structure the model using the most recent WHO mater-
nal cause of death categories as a framework [2]. In
instances where we asked for the effectiveness of an
intervention on a specific cause of death, we will use
affected fractions representing the proportion of maternal
deaths within the given WHO category represented by
that specific cause. For example, pre-eclampsia and
eclampsia represent a given proportion of maternal
deaths due to HDPs. To determine the effectiveness of
MgSO4 on deaths due to HDPs, this affected fraction will
be multiplied by the effectiveness of that intervention on
pre-eclampsia/eclampsia in order to determine the num-
ber of maternal deaths prevented within the larger cate-
gory. In addition, in the case of packages such as
BEmOC, LiST users will have the option to scale up cer-
tain individual interventions within the package or to
scale up the entire intervention package as a unit.
Several of the interventions in the Delphi were also
included in a 2011 review by Ronsmans and Campbell
[11]. This review discusses five interventions that were
included in our Delphi analysis: calcium supplementation,
MgSO4, and CEmOC for treatment of pre-eclampsia and
eclampsia, and hypertensive drugs and induction of labor
for the treatment of HDPs. The results of this review are
largely consistent with the results of our Delphi process
(see Table 3). Ronsmans and Campbell report that calcium
supplementation can reduce death or serious morbidity
due to HDPs by 20%, which is the same as our consensus
estimate for the effect of calcium supplementation on
deaths due to pre-eclampsia and eclampsia. In addition,
they report a 41% reduction in maternal death for those
treated with MgSO4 as compared to diazepam. Our con-
sensus effectiveness estimate was 60%, which may be rea-
sonable given that our questionnaire asked for an estimate
in comparison to the absence of treatment. Ronsmans and
Campbell also report a 84-99% reduction in mortality due
to severe pre-eclampsia and eclampsia for a package that
includes antenatal screenings, MgSO4, and early delivery.
This estimate is consistent with our effectiveness estimate
of 85% for CEmOC on pre-eclampsia and eclampsia. This
review may also shed light on why two interventions
related to HDPs in our Delphi analysis, antihypertensive
therapy and induction of labor, had relatively large IQRs
(greater than 20 percentage points) after the final round.
Ronsmans and Campbell report that while antihyperten-
sive drugs halve the risk of developing severe hyperten-
sion, their effect on mortality is unclear due to lack of
quality evidence. In addition, they conclude that while
induction of labor is effective in reducing adverse maternal
outcomes, it is impossible to assess the consistency of the
effect of induction of labor on HDP mortality based on
current evidence [11].
In 2006, WHO conducted a Delphi process to gener-
ate estimates for the efficacy of interventions to reduce
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maternal and neonatal mortality [unpublished manu-
script, WHO]. While several factors limit our ability to
directly compare these two analyses, the results of these
two Delphi processes are overall consistent and confir-
matory (see Table 4). For example, in our Delphi, the
estimated effectiveness of safe abortion services on
maternal death due to induced abortion was 95%, while
the efficacy estimate of a similar intervention in the
WHO Delphi (“management of abortion complications
to protect mothers with complications of abortion”) on
complications of abortion was 90%. Any discrepancies
found between our estimates and those of the WHO
Delphi can be explained by differences in the definitions
and delimitations of interventions and causes of death.
In our Delphi process, for example, the estimated effec-
tiveness of clean delivery practices on pregnancy-related
sepsis was 60%, as opposed to 75% in the WHO Delphi.
However, the WHO Delphi specifically asked for the effi-
cacy on one cause of sepsis, puerperal metritis. Thus, the
difference in estimates may be explained by the fact that
clean delivery practices are considered most effective
against puerperal sepsis, and less so against other causes
of sepsis, which were included in our definition. Hence,
there were no large discrepancies between the results of
our Delphi and those of WHO’s that could not be
explained by differences in definitions. Also of interest is
that overall, the uncertainty of estimates in the WHO
Delphi after three rounds were a few points narrower
than ours, given that the WHO defined a consensus esti-
mate as having an IQR of 15 percentage points or fewer.
One likely explanation for this difference is the form of
post-round feedback that was provided to the experts.
While our feedback included histograms of all responses
to the previous round, the WHO Delphi only used med-
ian values as a form of feedback, which may have led to
stronger pressure to move toward the median values on
subsequent rounds.
The different definitions and categories are due largely
to our use of the new WHO maternal cause of death
structure. It is important to note that the WHO process
was conducted nearly six years prior to ours [unpub-
lished manuscript, WHO]. In addition, the WHO Delphi
questionnaire asked for efficacy estimates as opposed to
effectiveness estimates, although the two are often con-
flated, and in our survey we specified that interventions
were timely and of high quality. Nevertheless, it is useful
to compare our findings against another comparable
review, which included a different panel of experts and
thus a somewhat different mix of nationalities and
professions.
There were two inconsistencies in our results that are
worth noting. First, effectiveness estimates for utero-
tonics on both prevention and treatment of PPH deaths
were higher (77.5% and 80%, respectively) than that for
AMTSL (70%). AMTSL is a package that includes utero-
tonics, controlled cord traction, and manual removal of
the placenta; thus, we would expect that AMTSL would
have the same or higher effectiveness on PPH than utero-
tonics in isolation. Similarly, the effectiveness estimate
for parenteral antibiotics, a component of BEmOC, on
pregnancy-related sepsis, was higher (80%) than that for
BEmOC (70%). While these inconsistencies are impor-
tant to be aware of, in both cases, the differing effective-
ness estimates are within their respective limits of
uncertainty. For this reason, we have chosen to include
these pairs in our model despite the inconsistencies.
Table 3 Comparison of Delphi effectiveness estimates with estimates from Ronsmans and Campbell 2011 [11]




























HDPs 50§ Antihypertensives HDPs Inconclusive
Induction of
labor





85 Antenatal screening for hypertension and proteinuria and treatment
of pre-eclampsia and eclampsia with MgS04 and early delivery in




§ = consensus not reached
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Furthermore, the fact that we were able to identify these
inconsistencies shows a benefit to our approach in that
had we only asked about packages as a whole, these dif-
ferences would not have been identifiable. In order to
handle these inconsistencies in the model, we will use the
higher effectiveness value of the individual component to
represent both the effectiveness of that component and
the package contained within.
There are several limitations to our methodology. An
important limitation of the Delphi method lies in the
method for defining consensus. While there has been
considerable discussion surrounding this issue, there
seems to be little agreement as to how to define consen-
sus [14]. Thus, the definition of consensus is inherently
determined at least partially by the subjective opinion of
the researcher. While we chose to define consensus as an
IQR of 20 percentage points or fewer, we recognize that
this number is somewhat arbitrary and useful primarily
as an analytical tool. As such, all estimates that were pro-
duced in this Delphi analysis will be included in the final
LiST model regardless of whether or not consensus was
reached, with corresponding uncertainty values included.
Another important limitation relates to the way in which
each individual expert interprets each question. While we
piloted the questionnaire with multiple maternal health
experts prior to beginning the Delphi process, there is
inevitable variation in interpretation. In addition,
although panel members had considerable experience
and expertise in their field, the Delphi method is inher-
ently based partially on the opinions and biases of indivi-
dual experts. For this reason, we sought out a
heterogeneous panel that would represent a diversity of
responses and opinions. However, our results, as well as
which interventions are included in the model, are influ-
enced by “hot topics” and current opinions in the global
health field and will inevitably evolve as the field evolves.
Furthermore, although all experts were provided with a
Word document with their responses to previous rounds
in addition to group responses, the online questionnaire
itself did not display individual responses. If those experts
who completed the questionnaire online were less aware
of their own responses than those who responded using
the Word document, this may have influenced their
responses to the subsequent round. Despite these limita-
tions, the Delphi method can be a powerful tool in situa-
tions where the evidence base is lacking or where it is
Table 4 Comparison of Delphi effectiveness estimates to WHO Delphi (2006)
LiST Delphi Study WHO Delphi Study (2006)
Intervention COD Est. Intervention COD Est. Notes
CEmOC PPH 90 Management of PPH to protect mothers with PPH
more than 500 ml after birth
PPH 90 WHO intervention could be carried





95 Safe abortion, Management of abortion complications






95 Management of prolonged or obstructed labor to
protect mothers with prolonged or obstructed labor
Obstructed
labor
90 WHO intervention could be carried









80 Puerperal metritis is only one cause
of pregnancy-related sepsis
IPTp/ITNs Malaria 72.5 Malaria prophylaxis or IPT provided during the
antenatal period in malaria endemic areas
Malaria 80 WHO intervention does not include
ITNs








60 Treatment of HDPs Pre-eclampsia
or eclampsia
80 WHO intervention also includes anti-
hypertensives and supportive care
Hypertensive
therapy
HDPs 50§ Treatment of HDPs Pre-eclampsia
or eclampsia
80 WHO intervention includes MgSO4
and supportive care in addition to
antihypertensives
CEmOC APH 90 Management of APH to protect mothers with APH APH 80 WHO intervention could be carried






60§ Clean delivery practices by traditional birth attendant Puerperal
metritis






80 Management of pre-labor rupture of membranes and




55 Puerperal metritis is only one cause
of preg.-rel. sepsis; WHO









50 Puerperal metritis is only one cause
of preg-rel. sepsis; WHO intervention
is only preventive
§ = consensus not reached, COD = cause of death
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not feasible to perform large-scale observational studies
and randomized trials due to ethical considerations. In
this case, this method has enabled us to use expert opi-
nion to generate estimates that will allow for the prioriti-
zation of public health programming.
The maternal mortality and other models used in
LiST are constantly evolving, requiring periodic updat-
ing to incorporate new and emerging evidence. In addi-
tion, it may be important to include certain risk factors
such as anemia in future maternal models, which may
impact maternal survival by affecting multiple causes of
maternal death simultaneously.
Conclusions
The results of this Delphi process suggest that there are
many existing maternal health interventions with high
estimated effectiveness. With the expansion of effective
delivery channels, existing interventions have the poten-
tial to have a large impact on reducing maternal mortal-
ity worldwide.
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